Home  »  News   »  Can Novavax Inc. Bounce Back? 52-Week Performance ...

Can Novavax Inc. Bounce Back? 52-Week Performance and Analyst Predictions

Novavax Inc. (NVAX) current stock price is $7.57. During the last trading session, the stock soared, reaching $8.08 after opening at $7.89. The stock’s lowest point was $7.67 before it closed at $7.71.

Novavax Inc.’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $32.41 on 09/19/22, with the lowest value being $5.61 on 03/23/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of NVAX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Novavax Inc.’s current trading price is -76.66% away from its 52-week high, while its distance from the 52-week low is 34.97%. The stock’s price range for this period has remained between $5.61 and $32.41. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.56 million for the day, which was noticeably lower compared to the shares’ average daily volume of 8.88 million over the last three months.

Financial Performance and Market Capitalization

Novavax Inc. (NVAX) has experienced a quarterly decline of -5.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 740.08M and boasts a workforce of 1992 employees.

Analysts’ Ratings For Novavax Inc.

As of right now, 2 analysts are rating Novavax Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 7.90, with a change in price of -0.15. Similarly, Novavax Inc. recorded 7,770,056 in trading volume during the last 100 days, posting a change of -1.97%.

NVAX Stock Stochastic Average

As of today, the raw stochastic average of Novavax Inc. over the last 50 days is at 18.38%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 15.06%. Further, the company’s Stochastic %K and %D values for the last 20 days were 22.49% and 22.36%, respectively.

NVAX Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -26.41%. However, over the last six months, the performance has been weaker by 27.14%. The price of NVAX increased 2.65% over the last 30 days. And in the last five days, it has fallen by -3.20%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts